Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
0.602
-0.054 (-8.16%)
Nov 21, 2024, 12:24 PM EST - Market open
Ensysce Biosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Net Income | -7.93 | -10.61 | -24.17 | -29.08 | 0.06 | -10.1 |
Depreciation & Amortization | - | - | - | 0 | 0 | 0 |
Other Amortization | 1.52 | 0.33 | 0.95 | 1.92 | - | - |
Loss (Gain) From Sale of Assets | - | - | -0 | - | - | - |
Stock-Based Compensation | 0.71 | 0.88 | 1.07 | 0.12 | 0.18 | 6.04 |
Other Operating Activities | 0.01 | -0.43 | -1.21 | 20.1 | -1.67 | 1.53 |
Change in Accounts Receivable | -1.68 | 0.18 | 0.16 | -0.44 | 0.17 | -0.17 |
Change in Accounts Payable | 0.74 | -1.23 | 2.64 | -1.42 | 1.18 | 0.37 |
Change in Other Net Operating Assets | -1.92 | 0.11 | 2.67 | 0.56 | -1.17 | 1.4 |
Operating Cash Flow | -8.54 | -10.78 | -17.89 | -8.24 | -1.25 | -0.94 |
Sale of Property, Plant & Equipment | - | - | 0 | - | - | - |
Investing Cash Flow | - | - | 0 | - | - | - |
Short-Term Debt Issued | - | - | - | - | - | 0.1 |
Long-Term Debt Issued | - | 1.61 | 7.53 | 14.38 | 1.1 | 0.4 |
Total Debt Issued | 1.61 | 1.61 | 7.53 | 14.38 | 1.1 | 0.5 |
Long-Term Debt Repaid | - | -1.45 | -2 | -0.96 | - | - |
Net Debt Issued (Repaid) | 0.7 | 0.15 | 5.53 | 13.42 | 1.1 | 0.5 |
Issuance of Common Stock | 3.75 | 9.05 | 3.78 | 6.89 | - | - |
Other Financing Activities | 6.78 | -0.45 | -0.55 | - | 0 | - |
Financing Cash Flow | 11.23 | 8.76 | 8.77 | 20.31 | 1.1 | 0.5 |
Net Cash Flow | 2.69 | -2.02 | -9.12 | 12.07 | -0.15 | -0.44 |
Free Cash Flow | -8.54 | -10.78 | -17.89 | -8.24 | -1.25 | -0.94 |
Free Cash Flow Margin | -193.16% | -483.29% | -708.87% | -233.41% | -31.73% | -53.02% |
Free Cash Flow Per Share | -1.32 | -4.76 | -99.42 | -98.10 | -18.13 | -0.94 |
Cash Income Tax Paid | 0 | 0 | 0 | 0 | 0 | 0 |
Levered Free Cash Flow | -5.46 | -7.42 | -11.19 | -14.66 | -3.27 | - |
Unlevered Free Cash Flow | -5.97 | -7.53 | -11.36 | -14.57 | -2.65 | - |
Change in Net Working Capital | 2.91 | 1.71 | -2.71 | 2.28 | 1.82 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.